NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc. Stock News
$0.532
+0.0177 (+3.44%)
At Close: Apr 19, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
03:49am, Wednesday, 03'rd Mar 2021
NEW YORK, March 3, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. ("Brainstorm" or the "Company") (NASDAQ: BCLI). Such investors
Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Brainstorm Cell Therapeutics Inc. (BCLI) Investigation
02:50pm, Wednesday, 24'th Feb 2021
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brainstorm Cell Therapeutics Inc. ("Brainstorm" or "th
BrainStorm Announces High-Level FDA Feedback on NurOwn® ALS Clinical Development Program
08:05am, Monday, 22'nd Feb 2021
NEW YORK, Feb. 22, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that it recen
Longeveron Seeks $25 Million IPO For Anti-Aging Efforts
01:54pm, Friday, 05'th Feb 2021
Longeveron Seeks $25 Million IPO For Anti-Aging Efforts
Why Infinity Pharma, Meridian Bio, More Biotech Stocks Are Moving Today
12:34pm, Friday, 05'th Feb 2021
Infinity Pharmaceuticals (NASDAQ: INFI) shares are trading higher Friday after JPMorgan upgraded the stock from Underweight to Neutral. Infinity Pharmaceuticals is a clinical-stage biopharmaceutical c
Why BrainStorm Cell Therapeutics Blasted 27.7% Higher Today
06:31pm, Thursday, 04'th Feb 2021
The company isn't giving up on a promising pipeline drug.
Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q4 2020 Results - Earnings Call Transcript
04:05pm, Thursday, 04'th Feb 2021
Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q4 2020 Results - Earnings Call Transcript
NEW YORK, Jan. 20, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today the peer-revi
BrainStorm Issues 2020 Letter to Shareholders
07:00am, Monday, 28'th Dec 2020
NEW YORK, Dec. 28, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the following letter
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 2 MS Study
07:00am, Friday, 18'th Dec 2020
NEW YORK, Dec. 18, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that all dosi
Hedge Funds Aren't Crazy About Brainstorm Cell Therapeutics Inc. (BCLI) Anymore
11:36pm, Thursday, 26'th Nov 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Brainstorm Cell Therapeutics News: 8 Things for BCLI Stock Investors to Know About the ALS Study
12:42pm, Tuesday, 17'th Nov 2020
Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. The post Brainstorm Cell Therapeutics News: 8 Things for BCLI Stock Investors
Why BrainStorm Cell Therapeutics Stock Imploded Today
12:31pm, Tuesday, 17'th Nov 2020
The company reported disappointing results from a pivotal clinical trial.
BrainStorm Announces Topline Results from NurOwn® Phase 3 ALS Study
07:30am, Tuesday, 17'th Nov 2020
NEW YORK, Nov. 17, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today topline resul
